Literature DB >> 28483401

Antibiotics for COPD exacerbations.

Wassim W Labaki1, MeiLan K Han2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28483401      PMCID： PMC5858908          DOI： 10.1016/S2213-2600(17)30166-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  9 in total

Review 1.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

2.  Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Authors:  Yvonne J Huang; Sanjay Sethi; Timothy Murphy; Snehal Nariya; Homer A Boushey; Susan V Lynch
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

3.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

Authors:  S Nouira; S Marghli; M Belghith; L Besbes; S Elatrous; F Abroug
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

Review 4.  Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Authors:  Daniela J Vollenweider; Harish Jarrett; Claudia A Steurer-Stey; Judith Garcia-Aymerich; Milo A Puhan
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

5.  Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Rohin Sethi; Karen Eschberger; Phyllis Lobbins; Xueya Cai; Brydon J B Grant; Timothy F Murphy
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

6.  Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.

Authors:  Carl Llor; Ana Moragas; Silvia Hernández; Carolina Bayona; Marc Miravitlles
Journal:  Am J Respir Crit Care Med       Date:  2012-08-23       Impact factor: 21.405

7.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

8.  Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

Authors:  Philip L Molyneaux; Patrick Mallia; Michael J Cox; Joseph Footitt; Saffron A G Willis-Owen; Daniel Homola; Maria-Belen Trujillo-Torralbo; Sarah Elkin; Onn Min Kon; William O C Cookson; Miriam F Moffatt; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2013-11-15       Impact factor: 21.405

9.  Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.

Authors:  Leopoldo N Segal; Jose C Clemente; Benjamin G Wu; William R Wikoff; Zhan Gao; Yonghua Li; Jane P Ko; William N Rom; Martin J Blaser; Michael D Weiden
Journal:  Thorax       Date:  2016-08-02       Impact factor: 9.139
  9 in total
  4 in total

1.  Antibiotic use prior to a lung cancer diagnosis: a population-based study.

Authors:  Lukas Löfling; Shahram Bahmanyar; Helle Kieler; Mats Lambe; Gunnar Wagenius
Journal:  Cancer Causes Control       Date:  2021-03-22       Impact factor: 2.506

2.  Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora.

Authors:  Li Ke; Luo Chen; Yuan Yaling; Gao Can; Lin Jun; Zhang Chuan
Journal:  Front Med (Lausanne)       Date:  2022-01-20

3.  Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Authors:  Daniela J Vollenweider; Anja Frei; Claudia A Steurer-Stey; Judith Garcia-Aymerich; Milo A Puhan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29

4.  Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.

Authors:  Ruan Spies; Matthew Potter; Ruan Hollamby; Stefan van der Walt; Ameer Hohlfeld; Eleanor Ochodo; Richard N van Zyl-Smit
Journal:  Syst Rev       Date:  2021-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.